C21 · Pharmaceuticals · CN
Clinical trial locations by country in China
China: 15% (clinical trial country use share, 2023).
- 15% Latest · 2023
- 3Records · 1 measures
Annual · 1 publisher · Next period 2024
Clinical trial country use share in China
Every record
3 records across 1 measure, newest first within each. Each period opens its record and evidence.
| Measure | Period | Value | Source |
|---|---|---|---|
| Clinical trial country use share | 2023 | 15% | IQVIA |
| Clinical trial country use share | 2021–2023 | 13% | IQVIA |
| Clinical trial country use share | 2019 | 10% | IQVIA |
Frequently asked questions
What is the latest clinical trial locations by country figure for China?
China: 15% clinical trial country use share in 2023.
Where does the China data come from?
3 records from 1 document by IQVIA. Each figure links to its record and its original source evidence.
Cite this page
Free to reuse under CC BY 4.0 with attribution to StatOrigin and the original publisher.
StatOrigin. (2026). Clinical trial locations by country in China [Data set]. Retrieved October 28, 2026, from https://statorigin.org/statistics/clinical-trial-locations-by-country/china
"Clinical trial locations by country in China." StatOrigin, 2026, https://statorigin.org/statistics/clinical-trial-locations-by-country/china. Accessed 28 Oct. 2026.
StatOrigin. "Clinical trial locations by country in China." Data set, 2026. Accessed October 28, 2026. https://statorigin.org/statistics/clinical-trial-locations-by-country/china.
@misc{statorigin_clinical_trial_locations_by_country_china_2026, title = {Clinical trial locations by country in China}, author = {{StatOrigin}}, year = {2026}, url = {https://statorigin.org/statistics/clinical-trial-locations-by-country/china}, note = {Data set. Accessed 2026-10-28} }